mbx: the income statement

MyFinsight

MBX Biosciences, Inc. (MBX)

For the quarter ending 2025-06-30, MBX made $2,394K in revenue. -$19,453K in net income. Net profit margin of -812.57%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Unrealized loss on marketable securities	-42
Total other comprehensive loss	-42
Research and development	17,724
General and administrative	4,081
Total operating expenses	21,805
Loss from operations	-21,805
Interest and other income, net	2,394
Net loss	-19,411
Total comprehensive loss	-19,453

Earnings per share, basic, total	-0.58
Earnings per share, diluted, total	-0.58
Weighted average number of shares outstanding, basic, total	33,446,385
Weighted average number of shares outstanding, diluted, total	33,446,385

Unit: Thousand (K) dollars (except for numbers of shares and EPS)